Your browser doesn't support javascript.
loading
Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil
Saraceni, Valeria; Pacheco, Antonio Guilherme; Golub, Jonathan E; Vellozo, Vitoria; King, Bonnie S; Cavalcante, Solange C; Eldred, Lois; Chaisson, Richard E; Durovni, Betina.
  • Saraceni, Valeria; SINAN.
  • Pacheco, Antonio Guilherme; Fiocruz. PROCC. Rio de Janeiro. BR
  • Golub, Jonathan E; Johns Hopkins University School of Medicine. Center for Tuberculosis Research.
  • Vellozo, Vitoria; SMSDC. Rio de Janeiro. BR
  • King, Bonnie S; Johns Hopkins University School of Medicine. Center for Tuberculosis Research.
  • Cavalcante, Solange C; SMSDC. Rio de Janeiro. BR
  • Eldred, Lois; Johns Hopkins University School of Medicine. Center for Tuberculosis Research.
  • Chaisson, Richard E; Johns Hopkins University School of Medicine. Center for Tuberculosis Research.
  • Durovni, Betina; SMSDC. Rio de Janeiro. BR
Braz. j. infect. dis ; 15(3): 249-252, May-June 2011. tab
Article Dans Anglais | LILACS | ID: lil-589957
ABSTRACT

BACKGROUND:

Tuberculosis is the most common opportunistic infection among HIV-infected patients in Brazil. Brazil's national policy for HIV care recommends screening for latent tuberculosis (TB) and implementing isoniazid preventive therapy (IPT).

OBJECTIVES:

We compared physician adherence to TB screening and other prevention and care policies among HIV primary care clinics in Rio de Janeiro City.

METHODS:

Data on performance of CD4 counts, viral load testing, tuberculin skin testing (TST) and IPT were abstracted from patient charts at 29 HIV clinics in Rio de Janeiro as part of the TB/HIV in Rio (THRio) study. Data on use of pneumocystis jiroveci pneumonia (PCP) prophylaxis were also abstracted from a convenience sample of 150 patient charts at 10 HIV clinics. Comparisons were made between rates of adherence to TB guidelines and other HIV care guidelines.

RESULTS:

Among the subset of 150 patients with confirmed HIV infection in 2003, 96 percent had at least one reported CD4 counts result; 93 percent had at least one viral load result reported; and, PCP prophylaxis was prescribed for 97 percent of patients with CD4 counts < 200 cells/mm³ or when clinically indicated. In contrast, 67 patients (45 percent) had a TST performed (all eligible); and only 11 percent (17) of eligible patients started IPT. Among 12,027 THRio cohort participants between 2003 and 2005, the mean number of CD4 counts and viral load counts was 2.5 and 1.9, respectively, per patient per year. In contrast, 49 percent of 8,703 eligible patients in THRio had a TST ever performed and only 53 percent of eligible patients started IPT.

CONCLUSION:

Physicians are substantially more compliant with HIV monitoring and PCP prophylaxis than with TB prophylaxis guidelines. Efforts to improve TB control in HIV patients are badly needed.
Sujets)


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Tuberculose / Types de pratiques des médecins / Infections opportunistes liées au SIDA / Adhésion aux directives / Isoniazide / Antituberculeux Type d'étude: Essai clinique contrôlé / Etude diagnostique / Guide de pratique / Étude pronostique Limites du sujet: Humains Pays comme sujet: Amérique du Sud / Brésil langue: Anglais Texte intégral: Braz. j. infect. dis Thème du journal: Maladies transmissibles Année: 2011 Type: Article Pays d'affiliation: Brésil / États-Unis d'Amérique Institution/Pays d'affiliation: Fiocruz/BR / SMSDC/BR

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Tuberculose / Types de pratiques des médecins / Infections opportunistes liées au SIDA / Adhésion aux directives / Isoniazide / Antituberculeux Type d'étude: Essai clinique contrôlé / Etude diagnostique / Guide de pratique / Étude pronostique Limites du sujet: Humains Pays comme sujet: Amérique du Sud / Brésil langue: Anglais Texte intégral: Braz. j. infect. dis Thème du journal: Maladies transmissibles Année: 2011 Type: Article Pays d'affiliation: Brésil / États-Unis d'Amérique Institution/Pays d'affiliation: Fiocruz/BR / SMSDC/BR